September 19, 2018 — DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced that its LVivo EF cardiac decision-support software is now available for purchase for GE’s Vscan Extend handheld, pocket-sized ultrasound. This collaboration is an outgrowth of work between DiA and GE Healthcare that began last year.
LVivo EF is the first AI-powered, ejection fraction (EF) automated app able to operate in the low-memory and processing-power environments of mobile ultrasound. EF evaluation is a key diagnostic criterion driving various treatment strategies in point-of-care (POC) settings — particularly in emergency medicine, intensive care and anesthesia.
Traditionally, most EF interpretation at POC is conducted through visual estimation, with clinician experience levels varying across POC settings. This means that achieving an accurate EF result in POC settings can be challenging. LVivo EF addresses this challenge by quickly and efficiently providing clinicians with left ventricle EF scoring and volume measurements via DiA’s advanced, proprietary AI technology and advanced pattern recognition algorithms that imitate the way the human eye identifies borders and motion.
LVivo EF is part of the DiA cardiac toolbox. The company offers additional cardiac ultrasound decision-support apps — which, like LVivo EF — are U.S. Food and Drug Administration (FDA)-cleared and CE Marked in the European Union.
DiA is exhibiting at the American College of Emergency Physicians (ACEP) Scientific Assembly, Oct. 1−3 in San Diego, where both DiA and GE Healthcare will demo the LVivo EF app on the GE Healthcare Vscan Extend.
For more information: www.dia-analysis.com, www.gehealthcare.com
December 05, 2024 
